Taiwan Society of Gene Therapy_Executive Supervisor

Executive SupervisorChing-Shiang Chi

Professional license
  • Certificate, Professor, Ministry of Education, Taiwan
  • Certificate, Child Neurologist
  • Certificate, Pediatric Intensivist
  • Certificate, Pediatric Emergency Physician
  • Certificate, Pediatrician
  • Certificate, Medical Doctor
Educational qualifications
  • M.D., College of Medicine, National Defense Medical University, Taipei, Taiwan
Experience
  1. Professor, Consultant Pediatric Neurologist, Children’s Medical Center, Taichung Veterans General Hospital, Taichung, Taiwan
  2. Professor, Ministry of Education, Taiwan
  3. Committee member, Treatment Task force, International League Against Epilepsy
  4. Chairperson and committee member, Rare Disease and Orphan Drug Application Review Committee, Ministry of Health and Welfare, Executive Yuan, Taiwan
  5. Chairperson, Enterovirus counseling of Central Taiwan, Center of Disease Control, Ministry of Health and Welfare, Executive Yuan, Taiwan
  6. Chairperson and expert, Acute flaccid paralysis (AFP) surveillance, Center of Disease Control, Ministry of Health and Welfare, Executive Yuan, Taiwan
  7. Committee member, Child Health Promotion, Ministry of Health and Welfare, Executive Yuan, Taiwan
  8. President, Asian Oceanian Child Neurology Association, 2017-2023
  9. Vice superintendent, Medical Education, Tungs’ Taichung MetroHarbor Hospital, 2017-2022
  10. Committee member, Task force, International League Against Epilepsy, 2018-2019
  11. Professor, College of Life Sciences, National Chung Hsing University, 2018-2022
  12. President, Taiwan Epilepsy Society, 2007-2009
  13. President, Taiwan Child Neurology Society, 2005-2008
  14. Director, Department of Pediatrics, Taichung Veterans General Hospital, Taiwan, 1983-2007
  15. Visiting Fellowship of Pediatric Neurology, Department of Neurology, College of Physicians and Surgeons at Presbyterian Hospital, New York City, 1982-1983
  16. Attending Physician, Department of Pediatrics, Taipei Veterans General Hospital, Taiwan, 1979-1983
  17. Resident and Chief Resident, Department of Pediatrics, Taipei Veterans General Hospital, Taiwan 1975-1979
Areas of expertise
  1. Child development
  2. Pediatric epilepsy
  3. Pediatric neurometabolic disorders
  4. Pediatric neurocritical care
  5. Pediatric neurological rare and difficult disorders
  6. Pediatric neurogenetics
Professional writings
  • Publications within 5 years (*: Corresponding author)
  • Lee HJ, Tsai CR, Chi CS, Liang HW, Lee HF*. Neurodevelopmental SHQ1 variants navigate the control of apoptosis, endoplasmic reticulum stress, and oxidative stress in neuroblastoma cells. Neuroscience 2025; 586: 1-8.
  • Liu SN, Chi CS, Lee HF*, Tsai CR, Yang YL, Wu PY. Genotype-Phenotype Variations in PURA Syndrome: Asian and Non-Asian Perspectives from a Systematic Review. Orphanet J Rare Dis 2025; 20: 376.
  • Yang YL, Lee HF*, Chi CS, Tsai CR, Liu SN, Wu PY. Refining the phenotypic and genotypic spectrum of WDR73-related Galloway-Mowat syndrome: a case series and a systematic review. Neurol Genet 2025; 11: e200280.
  • Yang YL, Lee HF*, Chi CS, Tsai CR, Wu PY, Liu SN. Cerebellar atrophy in genetic epileptic encephalopathies: a cohort study and a systematic review. Seizure: European Journal of Epilepsy 2024; 120:41-48.
  • Chi CS, Tsai CR, Lee HF*.Resolving unsolved whole-genome sequencing data in pediatric neurological disorders: a cohort study. (Chi CS and Tsai CR as co-first authors)Arch Dis Child 2024; 109: 730-735
  • Lee HF*, Chi CS. Congenital disorders of glycosylation and infantile epilepsy. Epilepsy Behav 2023; 142: 109214.
  • Chi CS, Tsai CR, Lee HF*. Biallelic SHQ1 variants in early infantile hypotonia and paroxysmal dystonia as the leading manifestation. (Chi CS and Tsai CR as co-first authors) Human Genet 2023; 142:1029-1041.
  • Wu PY, Chi CS, Tsai CR, Yang YL, Lee HF*. Long-term outcome of pediatric patients with anti-NMDA receptor encephalitis in a single center. Children 2023; 10: 182.
  • Chi CS, Lee HF*, Tsai CR. Clinico-Radiological Phenotype of UBTF c.628G>A Pathogenic Variant-Related Neurodegeneration in Childhood: A Case Report and Literature Review. Brain Sci 2022; 12: 1262.
  • Lee HF,Chi CS*, Tsai CR. Intrafamilial phenotypic variability in TBC1D24-TLDc homozygous mutation-related developmental and epileptic encephalopathy. Clin Neurol Neurosurg 2022; 214: 107142.
  • Trivisano M*, Muccioli L, Ferretti A, Lee HF, Chi CS, Bisulli F. Risk of SUDEP during infancy. Epilepsy Behav 2022; 131: 107896.
  • Lee HF, Hsu CC, Chi CS*, Tsai CR. Genotype-phenotype dissociation in two Taiwanese children with molybdenum cofactor deficiency caused by MOCS2 mutation. Neuropediatrics 2022; 53: 200-203.
  • Jan SL, Fu YC, Chi CS, Lee HF, Huang FL, Wang CC, Wei HJ, Lin MC, Chen PY, Hwang B. Catecholamine-induced secondary Takotsubo syndrome in children with severe enterovirus 71 infection and acute heart failure: A 20-year experience of a single institute. Front Cardiovasc Med 2021;8:752232.
  • Lee HF, Chi CS*, Tsai CR. Diagnostic yield and treatment impact of whole-genome sequencing in pediatric neurological disorders. Dev Med Child Neurol 2021; 63(8):934-938.